Authum invests in Rivaara Labs, diversifies portfolio with diagnostic stake

Authum Investment & Infrastructure Ltd. has entered into an agreement dated August 25, 2025, to acquire a 35.09% voting rights stake in Rivaara Labs Private Limited. This acquisition aligns with Authum's long-term strategy of diversifying its portfolio into stable and high-growth sectors. The total cost of acquisition is INR 36,56,83,001.

The acquisition involves a primary infusion of INR 36,00,00,000 to subscribe to 3,60,00,000 cumulative compulsorily convertible participating preference shares (CCPS) of Rivaara Labs. Additionally, Authum will purchase 1,58,42,000 equity shares and 4,09,88,011 CCPS from existing shareholders for INR 56,83,001.

Rivaara Labs, incorporated on October 18, 2019, operates diagnostic service centers, distributes diagnostic kits, and provides RT-PCR related services in India. The consummation of these transactions is expected by September 30, 2025.